Compare Quest Diagnostics Inc (DGX) vs Marathon Digital Holdings Inc (MARA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Marathon Digital Holdings Inc — how do they compare? Quest Diagnostics Inc trades at $237.51 (market cap $26.21B), while Marathon Digital Holdings Inc trades at $9.63 (market cap $3.74B). The key difference: Quest Diagnostics Inc is far larger — about 7× Marathon Digital Holdings Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Marathon Digital Holdings Inc pays none. Which is the better fit depends on your goals.
| DGX | MARA | |
|---|---|---|
Market Cap | $26.21B | $3.74B |
Sector | Health | Technology |
52-Week High | $238.50 | $22.84 |
52-Week Low | $173.49 | $6.73 |
Enterprise Value | $31.97B | $5.78B |
Dividend Yield | 1.45% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $237.99, up 0.15% on the day, near its 52-week high. The stock shows strong momentum with consecutive earnings beats in 2026, including Q2 EPS of $3.12 versus $2.82 expected. Revenue growth accelerated to $11.04 billion in 2025, with net income margin at 9.19%. Technical indicators signal a bullish trend, while analyst consensus is a $249.50 price target. Recent news highlights AI integration and raised 2026 outlook amid robust testing demand.
The outlook for DGX is positive, driven by earnings momentum, strategic partnerships, and healthcare demand. Investment opportunity lies in sustained growth and dividend yield, but risks include margin pressure from lower-margin deals and high debt levels. Valuation at a P/E of 25.21 requires continued execution to justify upside.
MARA Holdings trades at $9.675, down 1.2% on the day, with a bearish technical signal and negative earnings trends. The company reported a Q2 2026 net loss of $1.60 per share, missing estimates, while revenue declined to $804 million in 2026. Despite a 50% analyst buy rating and a $16.08 consensus price target, profitability remains challenged with a -429.71% net income margin. Recent news highlights a strategic pivot toward AI digital infrastructure amid Bitcoin mining headwinds.
The outlook is mixed: valuation ratios like P/E of 3.37 suggest potential undervaluation, but persistent losses and high debt-to-asset ratio of 49.43% pose significant risks. Upside depends on successful execution of the AI infrastructure strategy, while downside risks include continued earnings misses and cryptocurrency market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Marathon Digital Holdings Inc
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →
